ContraVir Pharmaceuticals, Inc. (Nasdaq: CTRV) announced that it has entered into a definitive merger agreement with privately-held Ciclofilin Pharmaceuticals, Inc ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE